nodes	percent_of_prediction	percent_of_DWPC	metapath
Letrozole—CYP3A4—Thiotepa—sarcoma	0.165	0.458	CbGbCtD
Letrozole—CYP3A4—Mitoxantrone—sarcoma	0.0711	0.197	CbGbCtD
Letrozole—CYP3A4—Vincristine—sarcoma	0.0489	0.136	CbGbCtD
Letrozole—CYP3A4—Etoposide—sarcoma	0.0448	0.124	CbGbCtD
Letrozole—CYP3A4—Doxorubicin—sarcoma	0.0306	0.0848	CbGbCtD
Letrozole—Lethargy—Doxorubicin—sarcoma	0.000955	0.00149	CcSEcCtD
Letrozole—Decreased appetite—Vincristine—sarcoma	0.000952	0.00149	CcSEcCtD
Letrozole—Dyspnoea—Mitoxantrone—sarcoma	0.000951	0.00149	CcSEcCtD
Letrozole—Cough—Etoposide—sarcoma	0.000948	0.00148	CcSEcCtD
Letrozole—Somnolence—Mitoxantrone—sarcoma	0.000948	0.00148	CcSEcCtD
Letrozole—Gastrointestinal disorder—Vincristine—sarcoma	0.000945	0.00148	CcSEcCtD
Letrozole—Fatigue—Vincristine—sarcoma	0.000944	0.00148	CcSEcCtD
Letrozole—Dyspepsia—Mitoxantrone—sarcoma	0.000939	0.00147	CcSEcCtD
Letrozole—Hypertension—Etoposide—sarcoma	0.000938	0.00147	CcSEcCtD
Letrozole—Constipation—Vincristine—sarcoma	0.000936	0.00146	CcSEcCtD
Letrozole—Pain—Vincristine—sarcoma	0.000936	0.00146	CcSEcCtD
Letrozole—Pain in extremity—Doxorubicin—sarcoma	0.000936	0.00146	CcSEcCtD
Letrozole—Dry skin—Epirubicin—sarcoma	0.000927	0.00145	CcSEcCtD
Letrozole—Decreased appetite—Mitoxantrone—sarcoma	0.000927	0.00145	CcSEcCtD
Letrozole—Chest pain—Etoposide—sarcoma	0.000925	0.00145	CcSEcCtD
Letrozole—Fatigue—Mitoxantrone—sarcoma	0.000919	0.00144	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000919	0.00144	CcSEcCtD
Letrozole—Discomfort—Etoposide—sarcoma	0.000914	0.00143	CcSEcCtD
Letrozole—Breast disorder—Epirubicin—sarcoma	0.000914	0.00143	CcSEcCtD
Letrozole—Pain—Mitoxantrone—sarcoma	0.000912	0.00143	CcSEcCtD
Letrozole—Constipation—Mitoxantrone—sarcoma	0.000912	0.00143	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Epirubicin—sarcoma	0.000911	0.00143	CcSEcCtD
Letrozole—Gastrointestinal pain—Vincristine—sarcoma	0.000895	0.0014	CcSEcCtD
Letrozole—Anaphylactic shock—Etoposide—sarcoma	0.000887	0.00139	CcSEcCtD
Letrozole—Asthenia—Thiotepa—sarcoma	0.000886	0.00139	CcSEcCtD
Letrozole—Infection—Etoposide—sarcoma	0.000881	0.00138	CcSEcCtD
Letrozole—Asthenia—Dactinomycin—sarcoma	0.000879	0.00138	CcSEcCtD
Letrozole—Feeling abnormal—Mitoxantrone—sarcoma	0.000879	0.00137	CcSEcCtD
Letrozole—Influenza—Epirubicin—sarcoma	0.000874	0.00137	CcSEcCtD
Letrozole—Pruritus—Thiotepa—sarcoma	0.000874	0.00137	CcSEcCtD
Letrozole—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000872	0.00136	CcSEcCtD
Letrozole—Tachycardia—Etoposide—sarcoma	0.000866	0.00135	CcSEcCtD
Letrozole—Abdominal pain—Vincristine—sarcoma	0.000865	0.00135	CcSEcCtD
Letrozole—Body temperature increased—Vincristine—sarcoma	0.000865	0.00135	CcSEcCtD
Letrozole—Skin disorder—Etoposide—sarcoma	0.000861	0.00135	CcSEcCtD
Letrozole—Dry skin—Doxorubicin—sarcoma	0.000858	0.00134	CcSEcCtD
Letrozole—Hyperhidrosis—Etoposide—sarcoma	0.000857	0.00134	CcSEcCtD
Letrozole—Angina pectoris—Epirubicin—sarcoma	0.000852	0.00133	CcSEcCtD
Letrozole—Urticaria—Mitoxantrone—sarcoma	0.000847	0.00133	CcSEcCtD
Letrozole—Breast disorder—Doxorubicin—sarcoma	0.000846	0.00132	CcSEcCtD
Letrozole—Anorexia—Etoposide—sarcoma	0.000845	0.00132	CcSEcCtD
Letrozole—Diarrhoea—Thiotepa—sarcoma	0.000845	0.00132	CcSEcCtD
Letrozole—Abdominal pain—Mitoxantrone—sarcoma	0.000843	0.00132	CcSEcCtD
Letrozole—Body temperature increased—Mitoxantrone—sarcoma	0.000843	0.00132	CcSEcCtD
Letrozole—Toxic epidermal necrolysis—Doxorubicin—sarcoma	0.000843	0.00132	CcSEcCtD
Letrozole—Diarrhoea—Dactinomycin—sarcoma	0.000838	0.00131	CcSEcCtD
Letrozole—Dizziness—Thiotepa—sarcoma	0.000816	0.00128	CcSEcCtD
Letrozole—Influenza—Doxorubicin—sarcoma	0.000809	0.00127	CcSEcCtD
Letrozole—Pollakiuria—Epirubicin—sarcoma	0.000808	0.00126	CcSEcCtD
Letrozole—Paraesthesia—Etoposide—sarcoma	0.000796	0.00125	CcSEcCtD
Letrozole—Weight increased—Epirubicin—sarcoma	0.000796	0.00124	CcSEcCtD
Letrozole—Weight decreased—Epirubicin—sarcoma	0.000791	0.00124	CcSEcCtD
Letrozole—Dyspnoea—Etoposide—sarcoma	0.000791	0.00124	CcSEcCtD
Letrozole—Somnolence—Etoposide—sarcoma	0.000788	0.00123	CcSEcCtD
Letrozole—Angina pectoris—Doxorubicin—sarcoma	0.000788	0.00123	CcSEcCtD
Letrozole—Asthenia—Vincristine—sarcoma	0.000786	0.00123	CcSEcCtD
Letrozole—Vomiting—Thiotepa—sarcoma	0.000785	0.00123	CcSEcCtD
Letrozole—Infestation—Epirubicin—sarcoma	0.000779	0.00122	CcSEcCtD
Letrozole—Infestation NOS—Epirubicin—sarcoma	0.000779	0.00122	CcSEcCtD
Letrozole—Vomiting—Dactinomycin—sarcoma	0.000779	0.00122	CcSEcCtD
Letrozole—Rash—Thiotepa—sarcoma	0.000778	0.00122	CcSEcCtD
Letrozole—Dermatitis—Thiotepa—sarcoma	0.000778	0.00122	CcSEcCtD
Letrozole—Headache—Thiotepa—sarcoma	0.000773	0.00121	CcSEcCtD
Letrozole—Rash—Dactinomycin—sarcoma	0.000773	0.00121	CcSEcCtD
Letrozole—Decreased appetite—Etoposide—sarcoma	0.000771	0.00121	CcSEcCtD
Letrozole—Gastrointestinal disorder—Etoposide—sarcoma	0.000766	0.0012	CcSEcCtD
Letrozole—Asthenia—Mitoxantrone—sarcoma	0.000765	0.0012	CcSEcCtD
Letrozole—Fatigue—Etoposide—sarcoma	0.000765	0.0012	CcSEcCtD
Letrozole—Stomatitis—Epirubicin—sarcoma	0.00076	0.00119	CcSEcCtD
Letrozole—Pain—Etoposide—sarcoma	0.000758	0.00119	CcSEcCtD
Letrozole—Constipation—Etoposide—sarcoma	0.000758	0.00119	CcSEcCtD
Letrozole—Urinary tract infection—Epirubicin—sarcoma	0.000758	0.00119	CcSEcCtD
Letrozole—Diarrhoea—Vincristine—sarcoma	0.000749	0.00117	CcSEcCtD
Letrozole—Sweating—Epirubicin—sarcoma	0.000747	0.00117	CcSEcCtD
Letrozole—Pollakiuria—Doxorubicin—sarcoma	0.000747	0.00117	CcSEcCtD
Letrozole—Hepatobiliary disease—Epirubicin—sarcoma	0.000737	0.00115	CcSEcCtD
Letrozole—Weight increased—Doxorubicin—sarcoma	0.000736	0.00115	CcSEcCtD
Letrozole—Nausea—Thiotepa—sarcoma	0.000733	0.00115	CcSEcCtD
Letrozole—Weight decreased—Doxorubicin—sarcoma	0.000732	0.00114	CcSEcCtD
Letrozole—Feeling abnormal—Etoposide—sarcoma	0.000731	0.00114	CcSEcCtD
Letrozole—Diarrhoea—Mitoxantrone—sarcoma	0.00073	0.00114	CcSEcCtD
Letrozole—Nausea—Dactinomycin—sarcoma	0.000728	0.00114	CcSEcCtD
Letrozole—Gastrointestinal pain—Etoposide—sarcoma	0.000725	0.00113	CcSEcCtD
Letrozole—Dizziness—Vincristine—sarcoma	0.000724	0.00113	CcSEcCtD
Letrozole—Infestation NOS—Doxorubicin—sarcoma	0.000721	0.00113	CcSEcCtD
Letrozole—Infestation—Doxorubicin—sarcoma	0.000721	0.00113	CcSEcCtD
Letrozole—Urticaria—Etoposide—sarcoma	0.000705	0.0011	CcSEcCtD
Letrozole—Haemoglobin—Epirubicin—sarcoma	0.000703	0.0011	CcSEcCtD
Letrozole—Stomatitis—Doxorubicin—sarcoma	0.000703	0.0011	CcSEcCtD
Letrozole—Body temperature increased—Etoposide—sarcoma	0.000701	0.0011	CcSEcCtD
Letrozole—Abdominal pain—Etoposide—sarcoma	0.000701	0.0011	CcSEcCtD
Letrozole—Urinary tract infection—Doxorubicin—sarcoma	0.000701	0.0011	CcSEcCtD
Letrozole—Haemorrhage—Epirubicin—sarcoma	0.0007	0.00109	CcSEcCtD
Letrozole—Hepatitis—Epirubicin—sarcoma	0.0007	0.00109	CcSEcCtD
Letrozole—Hypoaesthesia—Epirubicin—sarcoma	0.000696	0.00109	CcSEcCtD
Letrozole—Vomiting—Vincristine—sarcoma	0.000696	0.00109	CcSEcCtD
Letrozole—Sweating—Doxorubicin—sarcoma	0.000691	0.00108	CcSEcCtD
Letrozole—Urinary tract disorder—Epirubicin—sarcoma	0.000691	0.00108	CcSEcCtD
Letrozole—Rash—Vincristine—sarcoma	0.00069	0.00108	CcSEcCtD
Letrozole—Dermatitis—Vincristine—sarcoma	0.00069	0.00108	CcSEcCtD
Letrozole—Oedema peripheral—Epirubicin—sarcoma	0.000689	0.00108	CcSEcCtD
Letrozole—Connective tissue disorder—Epirubicin—sarcoma	0.000688	0.00108	CcSEcCtD
Letrozole—Urethral disorder—Epirubicin—sarcoma	0.000686	0.00107	CcSEcCtD
Letrozole—Headache—Vincristine—sarcoma	0.000686	0.00107	CcSEcCtD
Letrozole—Hepatobiliary disease—Doxorubicin—sarcoma	0.000682	0.00107	CcSEcCtD
Letrozole—Vomiting—Mitoxantrone—sarcoma	0.000678	0.00106	CcSEcCtD
Letrozole—Rash—Mitoxantrone—sarcoma	0.000672	0.00105	CcSEcCtD
Letrozole—Dermatitis—Mitoxantrone—sarcoma	0.000672	0.00105	CcSEcCtD
Letrozole—Headache—Mitoxantrone—sarcoma	0.000668	0.00105	CcSEcCtD
Letrozole—Erythema multiforme—Epirubicin—sarcoma	0.000662	0.00104	CcSEcCtD
Letrozole—Eye disorder—Epirubicin—sarcoma	0.000654	0.00102	CcSEcCtD
Letrozole—Haemoglobin—Doxorubicin—sarcoma	0.000651	0.00102	CcSEcCtD
Letrozole—Nausea—Vincristine—sarcoma	0.00065	0.00102	CcSEcCtD
Letrozole—Flushing—Epirubicin—sarcoma	0.000649	0.00102	CcSEcCtD
Letrozole—Cardiac disorder—Epirubicin—sarcoma	0.000649	0.00102	CcSEcCtD
Letrozole—Haemorrhage—Doxorubicin—sarcoma	0.000647	0.00101	CcSEcCtD
Letrozole—Hepatitis—Doxorubicin—sarcoma	0.000647	0.00101	CcSEcCtD
Letrozole—Hypoaesthesia—Doxorubicin—sarcoma	0.000644	0.00101	CcSEcCtD
Letrozole—Urinary tract disorder—Doxorubicin—sarcoma	0.000639	0.001	CcSEcCtD
Letrozole—Oedema peripheral—Doxorubicin—sarcoma	0.000638	0.000998	CcSEcCtD
Letrozole—Asthenia—Etoposide—sarcoma	0.000636	0.000996	CcSEcCtD
Letrozole—Connective tissue disorder—Doxorubicin—sarcoma	0.000636	0.000995	CcSEcCtD
Letrozole—Angiopathy—Epirubicin—sarcoma	0.000635	0.000993	CcSEcCtD
Letrozole—Urethral disorder—Doxorubicin—sarcoma	0.000635	0.000993	CcSEcCtD
Letrozole—Nausea—Mitoxantrone—sarcoma	0.000633	0.000991	CcSEcCtD
Letrozole—Mediastinal disorder—Epirubicin—sarcoma	0.000631	0.000987	CcSEcCtD
Letrozole—Pruritus—Etoposide—sarcoma	0.000627	0.000982	CcSEcCtD
Letrozole—Alopecia—Epirubicin—sarcoma	0.000618	0.000967	CcSEcCtD
Letrozole—Mental disorder—Epirubicin—sarcoma	0.000613	0.000959	CcSEcCtD
Letrozole—Erythema multiforme—Doxorubicin—sarcoma	0.000612	0.000958	CcSEcCtD
Letrozole—Malnutrition—Epirubicin—sarcoma	0.000609	0.000953	CcSEcCtD
Letrozole—Diarrhoea—Etoposide—sarcoma	0.000607	0.000949	CcSEcCtD
Letrozole—Eye disorder—Doxorubicin—sarcoma	0.000605	0.000947	CcSEcCtD
Letrozole—Cardiac disorder—Doxorubicin—sarcoma	0.000601	0.00094	CcSEcCtD
Letrozole—Flushing—Doxorubicin—sarcoma	0.000601	0.00094	CcSEcCtD
Letrozole—Tension—Epirubicin—sarcoma	0.000598	0.000935	CcSEcCtD
Letrozole—Dysgeusia—Epirubicin—sarcoma	0.000597	0.000933	CcSEcCtD
Letrozole—Nervousness—Epirubicin—sarcoma	0.000592	0.000926	CcSEcCtD
Letrozole—Back pain—Epirubicin—sarcoma	0.000589	0.000922	CcSEcCtD
Letrozole—Angiopathy—Doxorubicin—sarcoma	0.000587	0.000919	CcSEcCtD
Letrozole—Dizziness—Etoposide—sarcoma	0.000586	0.000918	CcSEcCtD
Letrozole—Mediastinal disorder—Doxorubicin—sarcoma	0.000584	0.000913	CcSEcCtD
Letrozole—Vision blurred—Epirubicin—sarcoma	0.000574	0.000898	CcSEcCtD
Letrozole—Alopecia—Doxorubicin—sarcoma	0.000572	0.000895	CcSEcCtD
Letrozole—Mental disorder—Doxorubicin—sarcoma	0.000567	0.000887	CcSEcCtD
Letrozole—Ill-defined disorder—Epirubicin—sarcoma	0.000565	0.000884	CcSEcCtD
Letrozole—Vomiting—Etoposide—sarcoma	0.000564	0.000882	CcSEcCtD
Letrozole—Malnutrition—Doxorubicin—sarcoma	0.000564	0.000882	CcSEcCtD
Letrozole—Rash—Etoposide—sarcoma	0.000559	0.000875	CcSEcCtD
Letrozole—Dermatitis—Etoposide—sarcoma	0.000559	0.000874	CcSEcCtD
Letrozole—Headache—Etoposide—sarcoma	0.000556	0.000869	CcSEcCtD
Letrozole—Tension—Doxorubicin—sarcoma	0.000553	0.000865	CcSEcCtD
Letrozole—Dysgeusia—Doxorubicin—sarcoma	0.000552	0.000864	CcSEcCtD
Letrozole—Malaise—Epirubicin—sarcoma	0.000549	0.000859	CcSEcCtD
Letrozole—Nervousness—Doxorubicin—sarcoma	0.000547	0.000856	CcSEcCtD
Letrozole—Vertigo—Epirubicin—sarcoma	0.000547	0.000856	CcSEcCtD
Letrozole—Leukopenia—Epirubicin—sarcoma	0.000545	0.000853	CcSEcCtD
Letrozole—Back pain—Doxorubicin—sarcoma	0.000545	0.000853	CcSEcCtD
Letrozole—Palpitations—Epirubicin—sarcoma	0.000538	0.000842	CcSEcCtD
Letrozole—Cough—Epirubicin—sarcoma	0.000532	0.000832	CcSEcCtD
Letrozole—Vision blurred—Doxorubicin—sarcoma	0.000531	0.000831	CcSEcCtD
Letrozole—Nausea—Etoposide—sarcoma	0.000527	0.000824	CcSEcCtD
Letrozole—Hypertension—Epirubicin—sarcoma	0.000526	0.000823	CcSEcCtD
Letrozole—Ill-defined disorder—Doxorubicin—sarcoma	0.000523	0.000818	CcSEcCtD
Letrozole—Chest pain—Epirubicin—sarcoma	0.000519	0.000811	CcSEcCtD
Letrozole—Arthralgia—Epirubicin—sarcoma	0.000519	0.000811	CcSEcCtD
Letrozole—Myalgia—Epirubicin—sarcoma	0.000519	0.000811	CcSEcCtD
Letrozole—Anxiety—Epirubicin—sarcoma	0.000517	0.000809	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	0.000515	0.000806	CcSEcCtD
Letrozole—Discomfort—Epirubicin—sarcoma	0.000512	0.000802	CcSEcCtD
Letrozole—Malaise—Doxorubicin—sarcoma	0.000508	0.000795	CcSEcCtD
Letrozole—Dry mouth—Epirubicin—sarcoma	0.000507	0.000793	CcSEcCtD
Letrozole—Vertigo—Doxorubicin—sarcoma	0.000506	0.000792	CcSEcCtD
Letrozole—Leukopenia—Doxorubicin—sarcoma	0.000505	0.000789	CcSEcCtD
Letrozole—Palpitations—Doxorubicin—sarcoma	0.000498	0.000779	CcSEcCtD
Letrozole—Anaphylactic shock—Epirubicin—sarcoma	0.000497	0.000778	CcSEcCtD
Letrozole—Oedema—Epirubicin—sarcoma	0.000497	0.000778	CcSEcCtD
Letrozole—Infection—Epirubicin—sarcoma	0.000494	0.000773	CcSEcCtD
Letrozole—Cough—Doxorubicin—sarcoma	0.000492	0.000769	CcSEcCtD
Letrozole—Nervous system disorder—Epirubicin—sarcoma	0.000488	0.000763	CcSEcCtD
Letrozole—Hypertension—Doxorubicin—sarcoma	0.000487	0.000761	CcSEcCtD
Letrozole—Tachycardia—Epirubicin—sarcoma	0.000485	0.000759	CcSEcCtD
Letrozole—Skin disorder—Epirubicin—sarcoma	0.000483	0.000755	CcSEcCtD
Letrozole—Hyperhidrosis—Epirubicin—sarcoma	0.000481	0.000752	CcSEcCtD
Letrozole—Arthralgia—Doxorubicin—sarcoma	0.00048	0.000751	CcSEcCtD
Letrozole—Chest pain—Doxorubicin—sarcoma	0.00048	0.000751	CcSEcCtD
Letrozole—Myalgia—Doxorubicin—sarcoma	0.00048	0.000751	CcSEcCtD
Letrozole—Anxiety—Doxorubicin—sarcoma	0.000478	0.000748	CcSEcCtD
Letrozole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	0.000477	0.000746	CcSEcCtD
Letrozole—Discomfort—Doxorubicin—sarcoma	0.000474	0.000742	CcSEcCtD
Letrozole—Anorexia—Epirubicin—sarcoma	0.000474	0.000741	CcSEcCtD
Letrozole—Dry mouth—Doxorubicin—sarcoma	0.000469	0.000734	CcSEcCtD
Letrozole—Anaphylactic shock—Doxorubicin—sarcoma	0.00046	0.00072	CcSEcCtD
Letrozole—Oedema—Doxorubicin—sarcoma	0.00046	0.00072	CcSEcCtD
Letrozole—Infection—Doxorubicin—sarcoma	0.000457	0.000715	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Epirubicin—sarcoma	0.000453	0.000709	CcSEcCtD
Letrozole—Nervous system disorder—Doxorubicin—sarcoma	0.000451	0.000706	CcSEcCtD
Letrozole—Insomnia—Epirubicin—sarcoma	0.00045	0.000703	CcSEcCtD
Letrozole—Tachycardia—Doxorubicin—sarcoma	0.000449	0.000702	CcSEcCtD
Letrozole—Skin disorder—Doxorubicin—sarcoma	0.000447	0.000699	CcSEcCtD
Letrozole—Paraesthesia—Epirubicin—sarcoma	0.000446	0.000698	CcSEcCtD
Letrozole—Hyperhidrosis—Doxorubicin—sarcoma	0.000445	0.000696	CcSEcCtD
Letrozole—Dyspnoea—Epirubicin—sarcoma	0.000443	0.000693	CcSEcCtD
Letrozole—Somnolence—Epirubicin—sarcoma	0.000442	0.000691	CcSEcCtD
Letrozole—Anorexia—Doxorubicin—sarcoma	0.000438	0.000686	CcSEcCtD
Letrozole—Dyspepsia—Epirubicin—sarcoma	0.000438	0.000685	CcSEcCtD
Letrozole—Decreased appetite—Epirubicin—sarcoma	0.000432	0.000676	CcSEcCtD
Letrozole—Gastrointestinal disorder—Epirubicin—sarcoma	0.000429	0.000671	CcSEcCtD
Letrozole—Fatigue—Epirubicin—sarcoma	0.000429	0.000671	CcSEcCtD
Letrozole—Pain—Epirubicin—sarcoma	0.000425	0.000665	CcSEcCtD
Letrozole—Constipation—Epirubicin—sarcoma	0.000425	0.000665	CcSEcCtD
Letrozole—Musculoskeletal discomfort—Doxorubicin—sarcoma	0.000419	0.000656	CcSEcCtD
Letrozole—Insomnia—Doxorubicin—sarcoma	0.000416	0.000651	CcSEcCtD
Letrozole—Paraesthesia—Doxorubicin—sarcoma	0.000413	0.000646	CcSEcCtD
Letrozole—Dyspnoea—Doxorubicin—sarcoma	0.00041	0.000642	CcSEcCtD
Letrozole—Feeling abnormal—Epirubicin—sarcoma	0.00041	0.000641	CcSEcCtD
Letrozole—Somnolence—Doxorubicin—sarcoma	0.000409	0.00064	CcSEcCtD
Letrozole—Gastrointestinal pain—Epirubicin—sarcoma	0.000407	0.000636	CcSEcCtD
Letrozole—Dyspepsia—Doxorubicin—sarcoma	0.000405	0.000633	CcSEcCtD
Letrozole—Decreased appetite—Doxorubicin—sarcoma	0.0004	0.000626	CcSEcCtD
Letrozole—Gastrointestinal disorder—Doxorubicin—sarcoma	0.000397	0.000621	CcSEcCtD
Letrozole—Fatigue—Doxorubicin—sarcoma	0.000397	0.00062	CcSEcCtD
Letrozole—Urticaria—Epirubicin—sarcoma	0.000395	0.000618	CcSEcCtD
Letrozole—Pain—Doxorubicin—sarcoma	0.000393	0.000615	CcSEcCtD
Letrozole—Constipation—Doxorubicin—sarcoma	0.000393	0.000615	CcSEcCtD
Letrozole—Abdominal pain—Epirubicin—sarcoma	0.000393	0.000615	CcSEcCtD
Letrozole—Body temperature increased—Epirubicin—sarcoma	0.000393	0.000615	CcSEcCtD
Letrozole—Feeling abnormal—Doxorubicin—sarcoma	0.000379	0.000593	CcSEcCtD
Letrozole—Gastrointestinal pain—Doxorubicin—sarcoma	0.000376	0.000588	CcSEcCtD
Letrozole—Urticaria—Doxorubicin—sarcoma	0.000365	0.000572	CcSEcCtD
Letrozole—Body temperature increased—Doxorubicin—sarcoma	0.000364	0.000569	CcSEcCtD
Letrozole—Abdominal pain—Doxorubicin—sarcoma	0.000364	0.000569	CcSEcCtD
Letrozole—Asthenia—Epirubicin—sarcoma	0.000357	0.000558	CcSEcCtD
Letrozole—Pruritus—Epirubicin—sarcoma	0.000352	0.00055	CcSEcCtD
Letrozole—Diarrhoea—Epirubicin—sarcoma	0.00034	0.000532	CcSEcCtD
Letrozole—Asthenia—Doxorubicin—sarcoma	0.00033	0.000516	CcSEcCtD
Letrozole—Dizziness—Epirubicin—sarcoma	0.000329	0.000514	CcSEcCtD
Letrozole—Pruritus—Doxorubicin—sarcoma	0.000325	0.000509	CcSEcCtD
Letrozole—Vomiting—Epirubicin—sarcoma	0.000316	0.000495	CcSEcCtD
Letrozole—Diarrhoea—Doxorubicin—sarcoma	0.000315	0.000492	CcSEcCtD
Letrozole—Rash—Epirubicin—sarcoma	0.000313	0.00049	CcSEcCtD
Letrozole—Dermatitis—Epirubicin—sarcoma	0.000313	0.00049	CcSEcCtD
Letrozole—Headache—Epirubicin—sarcoma	0.000311	0.000487	CcSEcCtD
Letrozole—Dizziness—Doxorubicin—sarcoma	0.000304	0.000476	CcSEcCtD
Letrozole—Nausea—Epirubicin—sarcoma	0.000295	0.000462	CcSEcCtD
Letrozole—Vomiting—Doxorubicin—sarcoma	0.000292	0.000458	CcSEcCtD
Letrozole—Rash—Doxorubicin—sarcoma	0.00029	0.000454	CcSEcCtD
Letrozole—Dermatitis—Doxorubicin—sarcoma	0.00029	0.000453	CcSEcCtD
Letrozole—Headache—Doxorubicin—sarcoma	0.000288	0.000451	CcSEcCtD
Letrozole—Nausea—Doxorubicin—sarcoma	0.000273	0.000427	CcSEcCtD
